General

“Article: P13 THE VALUE OF LABORATORY SCREENING VS. CLINICAL JUDGMENT IN HIT DIAGNOSIS: EXPERIENCES IN THREE BELGIAN HOSPITALS” has been added to your cart. View cart

Showing 1265–1280 of 1897 results

Article: P13 Monoclonal Gammopathy of Undetermined Significance (MGUS) after kidney transplantation: prevalence and clinical significance
€2.42 Add to cart
Article: P13 THE VALUE OF LABORATORY SCREENING VS. CLINICAL JUDGMENT IN HIT DIAGNOSIS: EXPERIENCES IN THREE BELGIAN HOSPITALS
€2.42 Add to cart
Article: P14 Cyclic thrombocytopenia in a patient with polycythemia vera: a case report
€2.42 Add to cart
Article: P14 PRELIMINARY EVALUATION OF ADAMTS-13 ANTIBODY TESTING
€2.42 Add to cart
Article: P14 The impact of the updated IMWG diagnostic criteria in a real-life SMM cohort: a single center experience
€2.42 Add to cart
Article: P15 Chronic myeloid leukemia initially presenting with acute haemopericardium and cardiac tamponade: case presentation and identification of a possible pitfall
€2.42 Add to cart
Article: P15 OPTIMISATION OF THE CALIBRATION CURVE FOR THE ACCURATE MEASUREMENT OF LOW FVIII LEVELS WITH ONE-STAGE ASSAYS
€2.42 Add to cart
Article: P15 Treatment patterns of Waldenström’s macroglobulinemia in Belgium
€2.42 Add to cart
Article: P16 HOW TO DEAL WITH SAMPLES WITH ERRORS ON APTT, PT AND FIBRINOGEN DUE TO OPTICAL CLOT DETECTION?
€2.42 Add to cart
Article: P16 Preleukemic phase of chronic myeloid leukemia presenting with an isolated peripheral basocytosis
€2.42 Add to cart
Article: P16 Real-Life Experience with Brentuximab Vedotin (Adcetris®): the Belgian National Registry
€2.42 Add to cart
Article: P17 Concurrent driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients
€2.42 Add to cart
Article: P17 Diagnostic strength of bone marrow aspirate versus biopsy in (smoldering) multiple myeloma patients
€2.42 Add to cart
Article: P17 ESTABLISHMENT OF A THROMBIN GENERATION THRESHOLD IN SEVERE HAEMOPHILIAC PATIENTS UNDER PROPHYLAXIS TO FURTHER DETERMINE AN ADDED VALUE OF THIS TEST IN THE PERSONALIZED TREATMENT: A PILOT STUDY
€2.42 Add to cart
Article: P18 Early discontinuation of lenalidomide in patients with relapsing or refractory multiple myeloma: predictive factors for stopping in the real life
€2.42 Add to cart
Article: P18 EVALUATION OF THE TAV8 (STAGO) AGGREGOMETER IN THE CLINICAL LABORATORY
€2.42 Add to cart

Article: P13 Monoclonal Gammopathy of Undetermined Significance (MGUS) after kidney transplantation: prevalence and clinical significance

Article: P13 THE VALUE OF LABORATORY SCREENING VS. CLINICAL JUDGMENT IN HIT DIAGNOSIS: EXPERIENCES IN THREE BELGIAN HOSPITALS

Article: P14 Cyclic thrombocytopenia in a patient with polycythemia vera: a case report

Article: P14 PRELIMINARY EVALUATION OF ADAMTS-13 ANTIBODY TESTING

Article: P14 The impact of the updated IMWG diagnostic criteria in a real-life SMM cohort: a single center experience

Article: P15 Chronic myeloid leukemia initially presenting with acute haemopericardium and cardiac tamponade: case presentation and identification of a possible pitfall

Article: P15 OPTIMISATION OF THE CALIBRATION CURVE FOR THE ACCURATE MEASUREMENT OF LOW FVIII LEVELS WITH ONE-STAGE ASSAYS

Article: P15 Treatment patterns of Waldenström’s macroglobulinemia in Belgium

Article: P16 HOW TO DEAL WITH SAMPLES WITH ERRORS ON APTT, PT AND FIBRINOGEN DUE TO OPTICAL CLOT DETECTION?

Article: P16 Preleukemic phase of chronic myeloid leukemia presenting with an isolated peripheral basocytosis

Article: P16 Real-Life Experience with Brentuximab Vedotin (Adcetris®): the Belgian National Registry

Article: P17 Concurrent driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients

Article: P17 Diagnostic strength of bone marrow aspirate versus biopsy in (smoldering) multiple myeloma patients

Article: P17 ESTABLISHMENT OF A THROMBIN GENERATION THRESHOLD IN SEVERE HAEMOPHILIAC PATIENTS UNDER PROPHYLAXIS TO FURTHER DETERMINE AN ADDED VALUE OF THIS TEST IN THE PERSONALIZED TREATMENT: A PILOT STUDY

Article: P18 Early discontinuation of lenalidomide in patients with relapsing or refractory multiple myeloma: predictive factors for stopping in the real life

Article: P18 EVALUATION OF THE TAV8 (STAGO) AGGREGOMETER IN THE CLINICAL LABORATORY